Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.030 Biomarker disease BEFREE We recommend prospective research to determine whether serum CEA estimation is useful as a component of routine pre-treatment workup for MACs arising from the salivary glands. 31828452 2020
Entrez Id: 4360
Gene Symbol: MRC1
MRC1
0.020 GeneticVariation disease BEFREE Mucinous adenocarcinoma was more likely to have mutations in genes coding for MMR proteins and mucin glycoproteins. 31729037 2019
Entrez Id: 9973
Gene Symbol: CCS
CCS
0.010 GeneticVariation disease BEFREE The MAC and SRCC groups also showed poorer overall CCS (60.9 and 32.5% vs. 67.8%, P < .001), with corresponding HR values of 1.271 (95% CI, 1.242-1.302, P < .001) and 1.724 (95% CI, 1.685-1.765, P < .001), respectively. 31601167 2019
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.100 GeneticVariation disease BEFREE HAMN and LAMN share high rates of KRAS and GNAS co-mutations supporting a common histogenesis and distinguishing them from MACA. 31491041 2020
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE The 10 cases of MACA harbored a similar prevalence of TP53 mutations (n=5, 50%) as HAMN but, unlike LAMN and HAMN, some harbored mutations in PIK3CA, APC, FBXW7, PTEN, and SMAD4. 31491041 2020
Entrez Id: 2778
Gene Symbol: GNAS
GNAS
0.100 GeneticVariation disease BEFREE HAMN and LAMN share high rates of KRAS and GNAS co-mutations supporting a common histogenesis and distinguishing them from MACA. 31491041 2020
Entrez Id: 4089
Gene Symbol: SMAD4
SMAD4
0.010 GeneticVariation disease BEFREE The 10 cases of MACA harbored a similar prevalence of TP53 mutations (n=5, 50%) as HAMN but, unlike LAMN and HAMN, some harbored mutations in PIK3CA, APC, FBXW7, PTEN, and SMAD4. 31491041 2020
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.010 Biomarker disease BEFREE This study adds to the existing evidence that CRP plays a role in ovarian carcinogenesis and suggests that inflammation may be particularly implicated in the etiology of endometrioid and mucinous carcinoma. 31462430 2019
Entrez Id: 8076
Gene Symbol: MFAP5
MFAP5
0.010 Biomarker disease BEFREE Reduction of MFAP5 staining was also observed in the stroma around mucin pools in 6 out of 9 sections from mucinous adenocarcinomas and in areas with high-grade dysplasia. 31422503 2020
Entrez Id: 6304
Gene Symbol: SATB1
SATB1
0.010 AlteredExpression disease BEFREE Besides this is the first report that shows different SATB1 expressions in conventional colorectal adenocarcinoma and mucinous carcinoma, and also in right-sided and left-sided CRC. 31290787 2019
Entrez Id: 238
Gene Symbol: ALK
ALK
0.060 GeneticVariation disease BEFREE Among the 897 non-mucinous adenocarcinomas, 61 PMPA with ≤90% mucin and 39 PMPA with >90% mucin, ALK rearrangements were found in 47 (5.2%) non-mucinous adenocarcinomas, 9 (14.8%) PMPA with ≤90% mucin and 12 (30.8%) PMPA with >90% mucin, respectively, with an ordinal association (coefficient, 95% CI=0.11, 0.06 to 0.17). 31285953 2019
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.080 Biomarker disease BEFREE The tumor showed pathologic complete response (pCR) after neoadjuvant chemotherapy with trastuzumab and pertuzumab. pCR of HER2-positive MC has rarely been described in literature. 31281734 2019
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.030 Biomarker disease BEFREE The nomogram based on multivariate logistic regression analysis showed that clinical T4 and N2 stages were the most significant independent clinical predictors for not achieving pCR, followed by mucinous adenocarcinoma and positive pre-treatment serum CEA results. 31263674 2019
Entrez Id: 1084
Gene Symbol: CEACAM3
CEACAM3
0.010 Biomarker disease BEFREE The nomogram based on multivariate logistic regression analysis showed that clinical T4 and N2 stages were the most significant independent clinical predictors for not achieving pCR, followed by mucinous adenocarcinoma and positive pre-treatment serum CEA results. 31263674 2019
Entrez Id: 1087
Gene Symbol: CEACAM7
CEACAM7
0.010 Biomarker disease BEFREE The nomogram based on multivariate logistic regression analysis showed that clinical T4 and N2 stages were the most significant independent clinical predictors for not achieving pCR, followed by mucinous adenocarcinoma and positive pre-treatment serum CEA results. 31263674 2019
Entrez Id: 5670
Gene Symbol: PSG2
PSG2
0.010 Biomarker disease BEFREE The nomogram based on multivariate logistic regression analysis showed that clinical T4 and N2 stages were the most significant independent clinical predictors for not achieving pCR, followed by mucinous adenocarcinoma and positive pre-treatment serum CEA results. 31263674 2019
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.100 GeneticVariation disease BEFREE In a multivariate analysis, female, advanced age, tumor type histology, mucinous carcinoma and positive tumor deposits were associated with a high KRAS mutation rate. 31162857 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.020 AlteredExpression disease BEFREE PD-L1 expression was more frequent in medullary and typical adenocarcinoma than in mucinous adenocarcinoma based on combined positive scores. 31152546 2019
Entrez Id: 7291
Gene Symbol: TWIST1
TWIST1
0.010 Biomarker disease BEFREE Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin. 31109821 2019
Entrez Id: 10953
Gene Symbol: TOMM34
TOMM34
0.010 AlteredExpression disease BEFREE The decreased levels of Tomm34 in type I carcinomas were particularly evident in clear cell and mucinous carcinomas. 30917858 2019
Entrez Id: 4134
Gene Symbol: MAP4
MAP4
0.010 Biomarker disease BEFREE Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. 30737623 2019
Entrez Id: 823
Gene Symbol: CAPN1
CAPN1
0.010 Biomarker disease BEFREE Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. 30737623 2019
Entrez Id: 6850
Gene Symbol: SYK
SYK
0.010 Biomarker disease BEFREE Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. 30737623 2019
Entrez Id: 7514
Gene Symbol: XPO1
XPO1
0.010 Biomarker disease BEFREE After neoadjuvant CRT, overall downstaging occurred in 44.4% of MAC and 72.4% of non-MAC (p=0.001), and positive CRM (≤1 mm) was observed more frequently in MAC (p<0.001). 30590006 2019
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.010 AlteredExpression disease BEFREE In conclusion, alteration of BRCA-1 expression is more frequent in serous than in mucinous carcinomas and is associated with tumors of higher grades and high proliferation rate. 30446260 2019